Stock Taper 
AMRN
$13.97
▼ DOWN 0.71% (-0.10)
KEY STATISTICS
Market Cap$288.94 M
52w High$20.90
52w Low$12.96
Dividend Yield—
Frequency—
P/E-139.70
Volume78.19K
Shares Out.20.68M
COMPANY
LEADERSHIP
CHIEF EXECUTIVE
Aaron D. Berg
COMPENSATION 2026
Salary$725,667
Stock Awards$1,391,250
Incentive Plan Pay$588,300
All Other Comp.$8,848
Total$3,540,366
ABOUT
SECTOR
Healthcare
WENT PUBLIC
April 1, 1993
METHOD OF GOING PUBLIC
IPO
FULL TIME EMPLOYEES
80
PRICE TARGET
Target High$3.00
Target Low$1.50
Target Median$2.00
Target Consensus$2.17
UPCOMING EARNINGS
DateNov 4, 2026
DayWednesday
Rev. Est.$43.76M
NOV
4
WED
SPLIT RECORD
| DATE | TYPE | RATIO |
|---|---|---|
| 2025-04-11 | Reverse | 1:20 |
| 2008-01-18 | Reverse | 1:10 |
| 1998-10-19 | Reverse | 1:10 |
PRICE
$13.97 ▼ DOWN 0.71% (−$0.10)About Amarin Corporation plc
https://www.amarincorp.com ↗Amarin Corporation plc develops and markets VASCEPA, an omega-3 product for reducing triglycerides in hypertriglyceridemia patients, operating mainly in the US, Europe, and Middle East, with collaborations to expand its therapeutic applications.
INDUSTRY
Drug Manufacturers - General
A PRODUCT AMARIN CORPORATION PLC IS KNOWN FOR
Vascepa (icosapent ethyl)
Vascepa is a prescription omega-3 medication by Amarin that lowers high triglycerides and reduces cardiovascular risk in high-risk adults, serving as the company's main revenue driver.
Revenue by Products
| Icon | PRODUCT | Q3-2025 | Q4-2025 | Q1-2026 | Q2-2026 |
|---|---|---|---|---|---|
 | Product | $48.56M | $46.54M ▼ | $43.33M ▼ | $39.08M ▼ |
 | Licensing And Royalty | $1.11M | $2.67M ▲ | $1.81M ▼ | $3.13M ▲ |
Revenue by Geography
| Map | REGION | Q3-2025 | Q4-2025 | Q1-2026 | Q2-2026 |
|---|---|---|---|---|---|
 | UNITED STATES | $40.87M | $41.11M ▲ | $35.62M ▼ | $32.24M ▼ |
 | Europe | $4.09M | $2.31M ▼ | $4.91M ▲ | $5.45M ▲ |
ETFS HOLDING THIS STOCK
ETFS HOLDING
4
LISTED HERE
3
RANKED BY POSITION SIZE
INSTITUTIONAL OWNERSHIP
SHARES OWNED
96.98%
HOLDERS
200
TOP 12 OF 200 · RANKED BY POSITION SIZE
Oppenheimerfunds, Inc.
Blackrock Fund Advisors
Sarissa Capital Management LP
Longitude (Cayman) Ltd.
Broadfin Capital, LLC
Price Michael F
Acadian Asset Management LLC
Raymond James Financial Services Advisors, Inc.
Sac Capital Advisors LP
Kynam Capital Management, LP
Ubs AG
Simplicity Solutions, LLC
RATINGS SNAPSHOT
Overall rating: C+
Discounted Cash Flow1
Return On Equity1
Return On Assets1
Debt To Equity4
Price To Earnings1
Price To Book4
Overall Score2
INSIDER TRADES
★
OFFICER: SVP, CFO
Fishman Peter L.
Purchase · 313 shares
2026-08-01
★
OFFICER: SVP, CFO
Fishman Peter L.
Sale · 155 shares
2026-08-01
★
OFFICER: SVP, CFO
Fishman Peter L.
Purchase · 313 shares
2026-08-01
★
OFFICER: SVP, CFO
Fishman Peter L.
Purchase · 2.4K shares
2026-07-01
SECTORS PEERS
| PEER | PRICE | |
|---|---|---|
 ANRO | $35.13 | COMPARE |
 SLN | $13.42 | COMPARE |
 ALT | $3.11 | COMPARE |
 LRMR | $4.01 | COMPARE |
 LYEL | $14.53 | COMPARE |
 CLLS | $3.40 | COMPARE |
 DBVT | $13.54 | COMPARE |
 ACIU | $2.65 | COMPARE |